Patterson, Shaun David http://orcid.org/0000-0001-7131-1533
Copland, Mhairi http://orcid.org/0000-0002-7655-016X
Funding for this research was provided by:
Cancer Research UK (CRCPJT\100006)
Article History
Accepted: 20 December 2022
First Online: 13 February 2023
Declarations
:
: SDP is funded by a Cancer Research UK Biomarker Award (CRCPJT\100006). Both SDP and MC are employees of the University of Glasgow.All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
: SDP declares that he has no conflict of interest. MC has received research funding from Cyclacel and Incyte; is/has been an advisory board member for Astellas, Novartis, Incyte, Jazz Pharmaceuticals, Pfizer and Servier; and has received honoraria from Astellas, Novartis, Incyte, Pfizer, and Jazz Pharmaceuticals.
: This article does not contain any studies with human or animal subjects performed by any of the authors.